feed,title,long_url,short_url
SeekingAlpha,Seres Therapeutics: Microbiome Therapeutics Amid High Operational Costs And Uncertain Profitability Path,https://seekingalpha.com/article/4616124,
SeekingAlpha,Nickel Underperforms As Surplus Builds,https://seekingalpha.com/article/4616137,
